Eight patients have been treated at Northern Care Alliance NHS Foundation Trust (NCA) in the world’s first-in-human study of graphene-brain interfaces to map and monitor brain activity and so improve precision during brain tumour surgery.
The study, sponsored by The University of Manchester and conducted with NCA, evaluated INBRAIN Neuroelectronics graphene-based cortical interface device. It showed a favourable perioperative safety profile with no device-related adverse events observed in all eight patients treated up to surgical discharge.

Many thanks to everyone who contributed to this important work, including the teams at Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, NIHR Manchester Biomedical Research Centre (BRC), investigators Kostas Kostarelos and David Coope, and the patients and their families.

Photograph is showing surgeons David Coope and Helen Maye operating on one of our patients.